Metropolitan Life Insurance Company (MetLife)’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,445
| Closed | -$36.3K | – | 1277 |
|
|
2024
Q1 | $36.3K | Hold |
1,445
| – | – | ﹤0.01% | 1563 |
|
|
2023
Q4 | $42.7K | Hold |
1,445
| – | – | ﹤0.01% | 1534 |
|
|
2023
Q3 | $45.7K | Sell |
1,445
-19
| -1% | -$600 | ﹤0.01% | 1453 |
|
|
2023
Q2 | $37.9K | Buy |
1,464
+486
| +50% | +$12.6K | ﹤0.01% | 1593 |
|
|
2023
Q1 | $23.5K | Hold |
978
| – | – | ﹤0.01% | 1798 |
|
|
2022
Q4 | $19.1K | Hold |
978
| – | – | ﹤0.01% | 2040 |
|
|
2022
Q3 | $20.5K | Hold |
978
| – | – | ﹤0.01% | 2018 |
|
|
2022
Q2 | $19K | Buy |
+978
| New | +$19K | ﹤0.01% | 2070 |
|